GNMT (Gene)

Organism:

Homo sapiens

Synonyms:CNPY3-GNMT readthrough, CNPY3-GNMT, ENTREZ:107080644, ENTREZ:27232, GNMT, HEL-S-182mP, HGNC:4415, MIM:606628, NM_001318856, NM_001318857, NM_001318858, NM_001318865, NM_018960, NP_001305785, NP_001305786, NP_001305787, NP_001305794, NP_061833, NR_134890, NR_134891, NR_134892, NR_134899, glycine N-methyltransferase

Omim:OMIM:606628

Id:2ba3449a-19e9-5dea-9132-98d6e1719888

Hgnc:HGNC:4415

Entrez:27232

Ensembl:ENSG00000124713

Description:glycine N-methyltransferase

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View GNMT's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with GNMT.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using GNMT.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for GNMT.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GNMT.

Results found

Linked to

	Label	Description
	GSE239688 canagliflozin 4 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE147876 GSE147877 enzalutamide MR42D 4 v 10 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE258991 enzalutamide DK1 [Tursiops] 5 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE147876 GSE147877 enzalutamide MR42D 2 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE210655 3 V 0 CISPLATIN MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE220097 enzalutamide LNCaP 4 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE252944 AKT inhibition 10 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE239688 4 V 1 CANAGLIFLOZIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE130246 enzalutamide UM 2 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE147876,GSE147877 2 V 7 ENZALUTAMIDE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS

GSE239688 canagliflozin 4 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE147876 GSE147877 enzalutamide MR42D 4 v 10 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE258991 enzalutamide DK1 [Tursiops] 5 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE147876 GSE147877 enzalutamide MR42D 2 v 7 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE210655 3 V 0 CISPLATIN MOUSE UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE220097 enzalutamide LNCaP 4 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE252944 AKT inhibition 10 v 6 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE239688 4 V 1 CANAGLIFLOZIN HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE130246 enzalutamide UM 2 v 3 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE147876,GSE147877 2 V 7 ENZALUTAMIDE HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.